Molecular Imaging for the Diagnosis of High-Risk Plaque

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue 12, 2003, Pages 1219-1224

  Sirol, M ^a,b   Fuster, V ^b   Toussaint, J F ^c   Fayad, Z A ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; GADOTERIC ACID; INTERCELLULAR ADHESION MOLECULE 1; IODINE 125; MATRIX METALLOPROTEINASE; RADIOISOTOPE; TECHNETIUM 99M; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROTIC PLAQUE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DISEASE COURSE; EARLY DIAGNOSIS; ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; MOLECULAR BIOLOGY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ARTERIOSCLEROSIS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RISK FACTORS;

EID: 1542329103     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Fuster V, Foyod ZA, Bodimon JJ. Acute coronary syndromes: biology. Lancet 1999; 353 (Suppl. 2): S115-SI19.
2. Ross R. Atherosclerosis - on inflommotory diseose. N Engl J Med 1999; 340: 115-26.
3. Fayad ZA, Fuster V. Clinicol imaging of the high-risk or vulneroble otherosclerotic plaque. Circ Res 2001; 89: 305-16.
4. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advonced types of atherosclerotic lesions ond o histological classification of otherosclerosis. A report from the Committee on Vosculor Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92: 1355-74.
5. Richordson PD, Davies MJ, Born GV. Influence of ploque configurotion ond stress distribution on fissuring of coronary otherosclerotic ploques. Loncet 1989; 2: 941-4.
6. Nissen SE, Yock P. Intravascular Ultrasound: Novel Pothophysiological Insights and Current Clinical Applications. Circulatian 2001; 103: 604-16.
7. Potwori P, Weissmon NJ, Bopport SA et al. Assessment of coronary plaque with opticol coherence tomogrophy ond high-frequency ultrasound. Am J Cordiol 2000; 85: 641-4.
8. Gronholdt ML, Nordestgoord BG, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001; 104: 68-73.
9. Callister TQ, Cooil B, Roya SP, Lippolis NJ, Russo DJ, Roggi P. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998; 208: 807-14.
10. Toussaint JF, Southern JF, Fuster V, Kantor HL. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1533-42.
11. Toussaint JF, LoMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, colcified, hemorrhogic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996; 94: 932-8.
12. Toussoint JF, Pochot-Clouord M, Bridol SL, Gouyo H, Berger G. Non-invasive imaging of atherosclerosis by MRI and ultrasonogrophy. Arch Mol Cœur 1999; 92: 349-54.
13. Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nucleor medicine. J Nucl Red 1997; 38: 1788-96.
14. Rudd JH, Warburton EA, Fryer TD et al. Imaging otherosclerotic ploque inflommation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-11.
15. Foyad ZA, Fuster V, Nikoloou K, Becker C. Computed tomography and magnetic resononce imoging for noninvasive coronary angiography and ploque imaging current and potential future concepts. Circulotion 2002; 106: 2026-34.
16. Foyod ZA, Fuster V, Fallon JT et al. Noninvosive In vivo Human Coronary Artery Lumen and Wall Imoging Using Black-Blood Magnetic Resonance Imoging. Circulation 2000; 102: 506-10.
17. Choudhury RP, Fuster V, Bodimon JJ, Fisher EA, Foyod ZA. MRI and chorocterization of atherosclerotic plaque: emerging applicotions and molecular imaging. Arterioscler Thromb Vosc Biol 2002; 22: 1065-74.
18. Kerwin W, Hooker A, Spilker M et al. Quantitotive magnetic resonance imoging onolysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003; 107: 851-6.
19. Schroeder S, Kopp AF, Baumbach A et al. Non-invosive detection ond evaluation of atherosclerotic coronory ploques with multislice computed tomogrophy. J Am Coll Cordial 2001; 37: 1430-5.
20. Weissleder R, Mahmood U. Molecular imoging. Radiology 2001; 219: 316-33.
21. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic ploque with ultrosmoll superparamagnetic particles of iron oxide in hyperlipidemic robbits Circulation 2001; 103: 415-22.
22. Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy. Circulation 2003; 107: 1092-5.
23. Tiukinhoy SD, Mahowald ME, Shively VP et al. Development of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery. Invest Radiol 2000; 35: 732-8.
24. Juliano L, Signore A, Violi F. Uptake of oxidized LDL by human atherosclerotic plaque. Circulation 1997; 96: 2093-4.
25. Tsimikas S. Non-invasive imaging of axidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol 2002; 90: 22L-27L.
26. Aime S, Cabella C, Colombatto S et al. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging 2002; 16: 394-406.
27. Schmitz SA, Coupland SE, Gust R et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol 2000; 35: 460-71.
28. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 2001; 14: 355-61.
29. Kooi ME, Cappendijk VC, Cleutjens KB et al. Accumulatian of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resanance imaging. Circulation 2003; 107: 2453-8.
30. Louie AY, Huber MM, Ahrens ET et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18: 321-5.
31. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse Arterioscler Thromb Vasc Biol 1998; 18: 842-51.
32. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednorski MD, Li KC. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998; 4: 623-6.
33. Sipkins DA, Gijbels K, Tropper FD, Bednarski M, Li KC, Steinman L. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol 2000; 104: 1-9.
34. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
35. Schmitz SA, Winterhalter S, Schiffler S et al. USPIO-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology 2001; 221: 237-43.
36. Yu X, Song SK, Chen J et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000; 44: 867-72.
37. Johansson LO, Bjornerud A, Ahlstrom HK, Ladd DL, Fujii DK. A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution. J Magn Reson Imaging 2001; 13: 615-8.